| (Not so) sudden impact
ASBMB President Jeremy Berg writes, in part, "Examples such as the development of imatinib are crucial in discussing the impact of biomedical research in our society, as they illustrate the ultimate effects of such research on people’s lives. They also illustrate the cumulative nature of such advances, as they involve concepts and tools developed by many scientists over many years or decades (often with different goals in mind) and the interactions between basic scientists, clinicians and the private sector in converting a set of discoveries into a tangible benefit for patients worldwide." |  |